Implantica finishes new multi-cavity production tool for RefluxStop® to support manufacturing ramp-up in the U.S. pending FDA approval

Contributed by: PR Newswire

Tags

Implantica-Reflux

More Like This

Implantica's RefluxStop™ garners strong interest at SAGES

Implantica deepens market penetration in Italy with the addition of the ninth RefluxStop™ Center of Excellence and several lined up to start near-term

Implantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop™ results

Implantica announces continuing progress in modular PMA application to FDA for RefluxStop™

Implantica announces further expansion of RefluxStop™ centers of excellence and patient access in Spain

Implantica opens a new RefluxStop™ center in a new region of Spain, addressing the fast-growing demand

Implantica announces Module 1 is accepted and closed by FDA in the PMA application for RefluxStop™

Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop™